/
Our mission is to simplify healthcare payments through our modern cloud-based software, enabling our healthcare clients to prioritize patient care and optimize their financial performance. Overview Waystar provides healthcare organizations with mission-critical AI-powered software that simplifies healthcare payments for providers across the continuum of care.
$22.27
$0.90 (-3.88%)
EOD Jul 17, 2026
22.68% operating margin is above average. ROIC at 3.90%. Note that capital returns lag the margin, the business may be capital-intensive despite high margins.
Revenue up 16.5% YoY with margins expanding 9.6pp.
At 33x earnings, the current multiple leaves limited room for execution misses or growth deceleration. Net debt of $1.40B represents 5.0x FCF, leverage limits flexibility.
33.2x earnings, 14.8x FCF. Not cheap, the quality is already reflected in the price. Upside from here requires either margin expansion or growth re-acceleration, not just continuation.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$1.16B
▲ +16.5% YoY
Net Income (TTM)
$126M
▲ +686.1% YoY
Op. Margin
22.87%
▲ +9.6pp YoY
ROIC
4.17%
▲ +1.6pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$294M
▲ +98.7% YoY
Op. Cash Flow (TTM)
$330M
▲ +82.4% YoY
Net Debt
$1.33B
Cash & Equiv.
$159M
3Y CAGR: +16.0%
3Y CAGR: +49.2%
Continue Research
At a P/E of 33.2 and a price-to-free-cash-flow of 14.8, Waystar Holding (WAY) trades below a two-stage DCF intrinsic value of about $69.23 per share, so at $22.27 the stock looks undervalued (210.9% below estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Waystar Holding scores 63/100 on Intrinsiqq's quality scorecard (a solid business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about $69.23 per share for WAY, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around $51.92. At today's $22.27, that puts the stock about 210.9% below estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Waystar Holding scores 63 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a solid business on these measures. Recent fundamentals include a 22.9% operating margin and a 4.2% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. WAY currently trades below its estimated intrinsic value and scores 63/100 on quality (solid). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.